Version 4.1 of AMCP Format for Formulary Submissions Updates Guidelines for Communicating Information on New Products and Uses to Payers

January 7, 2020

On December 23, 2019, the Academy of Managed Care Pharmacy (AMCP) released a new Format for Formulary Submissions. The new Format offers additional guidance for manufacturers on communicating with payers about clinical and health care economic information for unapproved products and unapproved uses.

Version 4.1 provides examples of the types of information AMCP recommends including in pre-approval dossiers (for unapproved products) and unapproved indication dossiers (for unapproved uses of approved products). AMCP has not made changes to its previous guidance regarding approved product dossiers.

Below are links providing additional information regarding the new version of the Format.

Learn more about implications of the new Format

The AMCP Format Version 4.1